JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -687.11 Million CNY | 37.77% |
| 2022 | -1.1 Billion CNY | 34.56% |
| 2021 | -1.68 Billion CNY | 32.69% |
| 2020 | -2.5 Billion CNY | -1315.72% |
| 2019 | -177.08 Million CNY | -136.2% |
| 2018 | -74.97 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -535.43 Million CNY | 22.07% |
| 2024 Q2 | -535.43 Million CNY | 0.0% |
| 2023 FY | -687.11 Million CNY | 37.77% |
| 2023 Q3 | -703.11 Million CNY | 20.3% |
| 2023 Q2 | -882.25 Million CNY | 1.55% |
| 2023 Q1 | -896.19 Million CNY | 18.84% |
| 2023 Q4 | -687.11 Million CNY | 2.28% |
| 2022 Q4 | -1.1 Billion CNY | 0.95% |
| 2022 Q2 | -1.36 Billion CNY | 1.0% |
| 2022 Q1 | -1.38 Billion CNY | 18.01% |
| 2022 FY | -1.1 Billion CNY | 34.56% |
| 2022 Q3 | -1.11 Billion CNY | 18.61% |
| 2021 Q1 | -2.09 Billion CNY | 16.46% |
| 2021 FY | -1.68 Billion CNY | 32.69% |
| 2021 Q4 | -1.68 Billion CNY | 0.89% |
| 2021 Q3 | -1.7 Billion CNY | 18.16% |
| 2021 Q2 | -2.08 Billion CNY | 0.67% |
| 2020 FY | -2.5 Billion CNY | -1315.72% |
| 2020 Q1 | 1.88 Billion CNY | 1166.94% |
| 2020 Q3 | -2.51 Billion CNY | -241.21% |
| 2020 Q2 | -737.93 Million CNY | -139.06% |
| 2020 Q4 | -2.5 Billion CNY | 0.43% |
| 2019 Q3 | 1.23 Billion CNY | 0.0% |
| 2019 FY | -177.08 Million CNY | -136.2% |
| 2019 Q1 | 133.99 Million CNY | 0.0% |
| 2019 Q4 | -177.08 Million CNY | -114.36% |
| 2018 FY | -74.97 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 4459.031% |
| SQZ Biotechnologies Company | -36.23 Million USD | -1796.115% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 30744.184% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 1705.669% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -10798.745% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 74207.461% |
| Mesoblast Limited | 55.85 Million USD | 1330.103% |
| Marizyme, Inc. | 18.56 Million USD | 3800.323% |
| Genus plc | 190.6 Million USD | 460.501% |
| Pharming Group N.V. | 109.8 Million USD | 725.764% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 79974.593% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 56704.398% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 101146.176% |
| ContraFect Corporation | -6.02 Million USD | -11302.489% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 59568.301% |
| IMV Inc. | 7.67 Million USD | 9057.853% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 12588.677% |
| MultiCell Technologies, Inc. | 90.04 USD | 763120935.184% |
| ONE Bio Corp. | 9.04 Million USD | 7700.789% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 5407.539% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 2348.851% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 110503.879% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 68285.282% |
| Biomind Labs Inc. | 711.4 Thousand USD | 96685.897% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 34466.147% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 5465.316% |
| Skye Bioscience, Inc. | -5.72 Million USD | -11909.566% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 191118.876% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 491583.792% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 12264.819% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 3458669.487% |
| GB Sciences, Inc. | 1.74 Million USD | 39423.969% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -373762.276% |
| CSL Limited | 10.52 Billion USD | 106.528% |
| Agentix Corp. | 37.63 Thousand USD | 1826025.434% |
| Enzolytics Inc. | 981.65 Thousand USD | 70095.396% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -101983.677% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 66.133% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 1681.973% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | -1361.572% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 9817.391% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -7672.86% |
| Zenith Capital Corp. | 10.06 Thousand USD | 6827544.356% |
| Genscript Biotech Corporation | -1.06 Billion USD | 35.259% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 16785.527% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 171088.107% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 28897.326% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 417775.629% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -3750931.772% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 30831.915% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 510438.015% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -93515.067% |
| Helix BioMedix, Inc. | -2.57 Million USD | -26635.62% |
| EV Biologics, Inc. | 1.36 Million USD | 50328.696% |
| Q BioMed Inc. | 4.06 Million USD | 17023.957% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 3488.804% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 1234.867% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | 4.47 Million USD | 15464.765% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 31304.356% |
| HST Global, Inc. | 96.79 Thousand USD | 709979.847% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -52451350.382% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 333299.494% |
| Halberd Corporation | 144.72 Thousand USD | 474885.276% |
| Resverlogix Corp. | 6.45 Million USD | 10751.279% |
| Cell Source, Inc. | 9.23 Million USD | 7542.766% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -3366785.535% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 108278.479% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 25467.725% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -5.9 Million USD | -11539.673% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 342916.516% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | 2.17 Million USD | 31641.2% |
| Kadimastem Ltd | -253.1 Thousand USD | -271377.112% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 505371.75% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 341516.32% |
| LadRx Corporation | -2.03 Million USD | -33640.46% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 108278.479% |
| Affymax, Inc. | -5.59 Million USD | -12176.47% |
| Itoco Inc. | 228.3 Thousand USD | 301063.185% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 13961.489% |
| Mobile Lads Corp. | 484.23 Thousand USD | 141997.685% |
| CytoDyn Inc. | 20.26 Million USD | 3491.146% |
| International Stem Cell Corporation | 2.59 Million USD | 26629.498% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | 1.89 Million USD | 36284.577% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -106199900.0% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -7413460.573% |
| Qrons Inc. | 351.42 Thousand USD | 195621.118% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 9016.608% |
| SYBLEU INC | 473.71 Thousand USD | 145148.278% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -275164.001% |
| Rebus Holdings, Inc. | 305 Thousand USD | 225383.279% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 15516.437% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 1101014.874% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 31605.984% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 20109.144% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 8133.602% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 89034.478% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -54869.12% |
| Neutra Corp. | 52.18 Thousand USD | 1316738.243% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -27506.027% |
| PureTech Health plc | -167.19 Million USD | -310.961% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -280460.047% |
| IXICO plc | -4.44 Million USD | -15359.569% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 5297.927% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 1352.692% |
| CSL Limited | 10.52 Billion USD | 106.528% |
| Cellectis S.A. | -43.81 Million USD | -1468.078% |